By Sriparna Roy May 28 (Reuters) - CVS Health will restore Eli Lilly's weight-loss injection Zepbound to its list of covered ...

Eli Lilly (LLY) stock is in focus as CVS Health (CVS) restores Zepbound coverage effective Oct 1, 2026, and adds Foundayo to ...

The pharmacy benefit manager dropped Zepbound a year ago in favor of rival Wegovy — now both Lilly and Novo Nordisk drugs ...

CVS Caremark is adding Zepbound, Eli Lilly’s obesity drug, back to its commercial insurance plan formularies, more than a ...

CVS Health will restore Eli Lilly’s weight-loss injection Zepbound to its list of covered drugs and also add the drugmaker’s ...

CVS Health’s decision to expand formulary coverage for key GLP-1 therapies marks a boost for Eli Lilly's obesity drug ...

CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.

CVS Health Corporation (NYSE:CVS) is one of the Best Undervalued Stocks to Buy Under $100. On May 5, the company announced that its pharmacy benefit arm is updating its commercial formularies ...

CVS Health has announced a significant expansion of its coverage for Eli Lilly's weight-loss medications, confirming it will ...